Stay updated on Pembrolizumab Combo in Small Cell Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Small Cell Lung Cancer Clinical Trial page.

Latest updates to the Pembrolizumab Combo in Small Cell Lung Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRevision: v3.4.2 added and Revision: v3.4.1 removed, indicating a minor platform update that does not affect study details or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check16 days agoChange DetectedRevision history updated: added Revision v3.4.1 and removed Revision v3.4.0.SummaryDifference0.0%

- Check31 days agoChange DetectedIntroduces a Show glossary control on the page. Makes minor textual changes to labels (Last Update Submitted that Met QC Criteria; No FEAR Act Data) and updates the revision from v3.3.4 to v3.4.0.SummaryDifference0.1%

- Check39 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; no visible changes to the study details or page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check67 days agoChange DetectedThe Locations section has been expanded to include numerous geographic sites across the United States, Canada, Australia, and Europe. The page layout has been reorganized to reflect these sites.SummaryDifference2%

- Check89 days agoChange DetectedPage revision updated from v3.3.1 to v3.3.2.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab Combo in Small Cell Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Small Cell Lung Cancer Clinical Trial page.